Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.

Apple Cider Vinegar is based on reporting by the award-winning journalists who first uncovered Belle Gibson's lies.

As Auburn football puts a bow and ribbon on the 2025 recruiting cycle, here's a full look at where its class stands, including team rankings and a signee rundown.

Samsung’s flagship smartphones don’t live nearly in the same vein they once did. They’re not as flashy, they’re not ...

A local vascular surgeon has highlighted a simple injection that could alleviate leg pain for those experiencing heaviness or ...

If you’re looking to get summer ready, Jiva Med Spa could help! Medical Director & CEO Dr. Rakesh Nanda joined Living Dayton ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...

An Omaha artist is putting her unique fingerprint on the world by connecting science and nature. This week, she’s in the ...

In this Healio Video Perspective from Retina 2025, Roger A. Goldberg, MD, MBA, discusses the role of multimodal imaging in geographic atrophy in the era of complement inhibitors.Imaging confirms the ...